Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design

Neuromuscular Disorders - United Kingdom
doi 10.1016/j.nmd.2016.06.402
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Human Trigeminovascular Biomarker for Antimigraine Drugs: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial With Sumatriptan

Cephalalgia
MedicineNeurology
2016English

CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Donepezil for Dementia in Parkinson's Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2005English

TRYMS: The Ethical and Practical Considerations of a Double-Blind Placebo Controlled Randomised Clinical Trial

Trials
MedicinePharmacology
2015English

CONFIRM: A Double-Blind, Placebo-Controlled Phase III Clinical Trial Investigating the Effect of Nivolumab in Patients With Relapsed Mesothelioma: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2018English

Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial

The Lancet
Medicine
2012English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy